Inevestigator Site 1074 — Washington D.C., District of Columbia

Inevestigator Site 1074 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Inevestigator Site 1074 has participated in 1 clinical trials.

Therapeutic areas: Acute Coronary Syndrome.

Sponsors: Anthera Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Inevestigator Site 1074?

Inevestigator Site 1074 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Inevestigator Site 1074 conducted?

Inevestigator Site 1074 has 1 clinical trials on record. Their work covers Acute Coronary Syndrome.

Is Inevestigator Site 1074 accredited by Crixeo Health?

Inevestigator Site 1074 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Inevestigator Site 1074?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.